Cancer Research UK logo.
SearchDonate
  • Search

A trial of everolimus and a type of internal radiotherapy for neuroendocrine tumours (COMPETE)

Overview

Cancer types:

Carcinoid, Neuroendocrine tumour (NET), Secondary cancers

Status:

Closed

Phase:

Phase 3

Details

This trial is for people with a neuroendocrine tumour (NET) that started in the pancreas or the gastrointestinal tract. The gastrointestinal tract includes the:

  • stomach

  • bowel

It is for people who have a NET that has spread to other parts of the body (metastatic) or that cannot be removed with surgery.

Everyone taking part has certain proteins on the surface of their cancer cells called somatostatin receptors.

Recruitment start: 18 April 2018

Recruitment end: 30 April 2022

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Prof Dr Shaunak Navalkissoor

Supported by

ITM Solucin

Last reviewed: 14 Mar 2023

CRUK internal database number: 15510

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.